ATG3 and central nervous system cancer: The results showed that mRNA expression of ATG3 (HR = 0.63, 95% CI: 0.40–0.99, p = 0.05), ATG4C (HR = 1.54, 95% CI: 1.16–2.01, p = 3 × 10− 3) and ATG5 (HR = 0.61, 95% CI: 0.43–0.86, p = 5 × 10− 3) were independent OS prognostic factors in gliomas patients (Table 2).